Suchergebnisse - "Fujiyama, Shunichiro"

PubPharm (155)

1

Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance

enthalten in: Journal of gastroenterology | 2024

von Suzuki, F. | Hosaka, T. | Suzuki, Y. | +8

2

Impact of genetic polymorphism on personalized diet and exercise program for steatotic liver disease

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Akuta, N. | Kawamura, Y. | Fujiyama, S. | +15

3

Impact of genetic polymorphism on personalized diet and exercise program for steatotic liver disease

enthalten in: Hepatology Research | 2024

von Akuta, N. | Kawamura, Y. | Fujiyama, S. | +15

4

A new imaging classification for safer radial access visceral intervention of the liver and optimal case selection : A preliminary report

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2023

von Kawamura, Y. | Akuta, N. | Fujiyama, S. | +8

5

Correction to : Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma

enthalten in: Clinical journal of gastroenterology | 2023

von Kawamura, Y. | Akuta, N. | Shindoh, J. | +14

ErratumFor: Clin J Gastroenterol. 2023 Feb;16(1):1-12. - PMID 36344851

6

Two Cases of Advanced Hepatocellular Carcinoma Who Responded Well to the Combination of Durvalumab Plus Tremelimumab After Disease Progression During Atezolizumab Plus Bevacizumab Therapy Under Bevacizumab Withdrawal

enthalten in: Cureus | 2023

von Kawamura, Y. | Akuta, N. | Fujiyama, S. | +2

7

Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma

enthalten in: Cancers | 2023

von Kawamura, Y. | Akuta, N. | Shindoh, J. | +14

8

Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictors

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2023

von Akuta, N. | Kawamura, Y. | Fujiyama, S. | +15

9

Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma

enthalten in: Clinical journal of gastroenterology | 2023

von Kawamura, Y. | Akuta, N. | Shindoh, J. | +14

ErratumIn: Clin J Gastroenterol. 2023 Oct;16(5):791. - PMID 37392310

10

The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment : An Imaging-Based Analysis

enthalten in: Oncology | 2023

von Muraishi, N. | Kawamura, Y. | Akuta, N. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]